Fintel reports that on January 31, 2025, Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (NasdaqGM:ACRV) with a Overweight recommendation. Analyst Price Forecast Suggests 260.44% Upside ...

Cantor Fitzgerald reiterated a Neutral rating on Intel Corporation (NASDAQ:INTC) with a consistent price target of $22.00.

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...

Cantor Fitzgerald analyst C J Muse maintained a Hold rating on Intel (INTC – Research Report) yesterday and set a price target of $22.00. The ...

Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.

Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" ...

Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...

There are few things music geeks love more than an unearthed, previously unknown recording, and that’s exactly what’s in store for fans of iconic jazz singer Ella Fitzgerald. On Feb. 28 ...

On Friday, ServiceNow (NYSE:NOW)stock received a new Overweight rating from Cantor Fitzgerald, accompanied by a price target of $1,332.00. The firm's initiation of coverage on the cloud computing ...

On Wednesday, Cantor Fitzgerald analysts maintained an Overweight rating on Applied Blockchain Inc (NASDAQ: APLD) stock. The revision follows Applied Digital Corp.'s disclosure of its second ...